Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-30

Clinical Trial Update: Adding Dexmedetomidine to Bupivacaine for Bilateral Erector Spinae Block [Phase 4]

View source ↗

Summary

A Phase 4 trial updates the use of dexmedetomidine added to bupivacaine for bilateral erector spinae block in lumbar fusion surgeries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Erector Spinae Block, Lumbar Fusion Surgeries | Phase 4 | Status: UNKNOWN